Le Lézard
Classified in: Health
Subject: SVY

The Global Anesthesia Face Masks Market is expected to grow by USD 9.85 mn during 2020-2024, progressing at a CAGR of 4% during the forecast period


NEW YORK, Jan. 29, 2020 /PRNewswire/ --

Global Anesthesia Face Masks Market 2020-2024
The analyst has been monitoring the global anesthesia face masks market and it is poised to grow by USD 9.85 mn during 2020-2024, progressing at a CAGR of 4% during the forecast period. Our reports on anesthesia face masks market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

Read the full report: https://www.reportlinker.com/p03884116/?utm_source=PRN

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising number of surgical procedures. In addition, technological advances in anesthesia is anticipated to boost the growth of the anesthesia face masks market as well.

Market Segmentation
The global anesthesia face masks market is segmented as below:
Product
? Disposable Face Masks
? Reusable Face Masks

Geographic segmentation
? Asia
? Europe
? North America
? ROW

Key Trends for anesthesia face masks market growth
This study identifies technological advances in anesthesia as the prime reasons driving the anesthesia face masks market growth during the next few years.
Prominent vendors in anesthesia face masks market
We provide a detailed analysis of around 25 vendors operating in the anesthesia face masks market, including some of the vendors such as Ambu AS, Armstrong Medical Ltd., General Electric Co., HSINER Co. Ltd., Intersurgical Ltd., Koninklijke Philips NV, Medtronic Plc, Smiths Group Plc, Teleflex Inc. and Vyaire Medical Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.


Read the full report: https://www.reportlinker.com/p03884116/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 08:53
Carolinas ContinueCARE Hospital at Pineville Celebrates 20 Years of Service
Carolinas ContinueCARE Hospital at Pineville celebrates its 10th anniversary, as well as 20 total years of providing long-term acute care services to its community. Carolinas ContinueCARE Hospital at Pineville is located in the heart of Charlotte,...

at 08:52
Satchel Kiefer Promoted to Chief Revenue Officer and Julie Walker Joins Knowtion Health as Senior Vice President of Sales and Marketing
Knowtion Health, a leader in insurance claims resolution and recovery to improve revenue cycle outcomes for hospitals and health systems throughout the United States, announced that Satchel Kiefer has been promoted to Chief Revenue Officer,...

at 08:50
Health Advocate Partners with Tava Health to Expand Access to Virtual Therapy
Health Advocate, a leading provider of integrated health advocacy and navigation, well-being, and behavioral health programs, announced it has partnered with Tava Health to expand access to digital teletherapy and enable members to seamlessly connect...

at 08:50
SIGNET JEWELERS RAISES RECORD-BREAKING $8.75M BENEFITING ST. JUDE CHILDREN'S RESEARCH HOSPITAL®
Signet Jewelers, the world's largest retailer of diamond jewelry,...

at 08:45
Tris Pharma Launches Digital Health Business to Develop and Commercialize Digital Products for ADHD
Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, has entered into a licensing agreement with Braingaze Ltd. (Braingaze) and...

at 08:45
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the pricing of its "reasonable best efforts" public offering of 15,197,500 shares of common stock (or...

More news about Health...


News published on and distributed by: